Great post @Pumice. Negative cashflow of $16 million is probably best case scenario for IDX in FY24 barring any other unforeseen cost blowouts. There is a very real possibility that IDX will have to raise capital to sure up the balance sheet within the next 6 months too. Given the negative sentiment and broker downgrades it would likely be at a steep discount.
I sold out today at an average of 1.8716 booking a very small profit. I really like the radiology space but I think CAJ has the stronger balance sheet and more prudent financial management so may look to increase my holding there. HLS and SHL both look interesting at current levels too.
Ann: Change of Director's Interest Notice - Andrew Fay, page-6
Add IDX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.52 |
Change
0.140(5.88%) |
Mkt cap ! $589.5M | |||
| Open | High | Low | Value | Volume |
| $2.35 | $2.56 | $2.32 | $1.420M | 569.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 29702 | $2.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.55 | 2376 | 1 |
View Market Depth
| Last trade - 16.10pm 13/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.52 |
Change
0.140 ( 6.30 %) |
||||
| Open | High | Low | Volume | ||
| $2.37 | $2.56 | $2.36 | 107430 | ||
| Last updated 15.59pm 13/06/2024 ? | |||||
| IDX (ASX) Chart |